SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
ISIN US6177001095
USD
  • Morningstar Inc
    Börse Börse Berlin
    Symbol MRS
    EUR
  • Morningstar Inc
    Börse Börse Frankfurt
    Symbol MRS
    EUR
  • MORNINGSTAR INC
    Börse Gettex System der Börse München
    Symbol MRS
    EUR
  • MORNINGSTAR INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol MRS
    EUR
  • MORNINGSTAR INC
    Börse Börse Stuttgart
    Symbol MRS
    EUR
  • ISIN US6177001095 WKN: A0EADM
    Symbol MORN
    USD
  • Symbol MRS
    EUR
ISIN US6177001095
WKN A0EADM
Symbol MORN
Währung USD
Firmenname Morningstar, Inc
Marktkapitalisierung 9.355.622.784 (+- 12%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

10.475.245.568 oder 8.236.000.000

Mitarbeiter 10.195 (+- 22%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

7.979 oder 12.411 Mitarbeiter

KGV 47.14
EBITDA 328.600.000
Buchwert 29.638

Zahlte zuletzt am 08.04.2021 eine Dividende von 0,315 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die Dividendenrendite entsprach 0,13 % p. a. beim aktuellen Kurs von 193 EUR +0,52% 

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 193 EUR +0,52% 

353 News & Informationen zur Morningstar Inc Aktie

  • The Zacks Analyst Blog Highlights: Kinder Morgan, Apache Corp, Whiting Petroleum, Oceaneering International and Petrobras
    zacks.com

    The Zacks Analyst Blog Highlights: Kinder Morgan, Apache Corp, Whiting Petroleum, Oceaneering International and Petrobras

    The Zacks Analyst Blog Highlights: Kinder Morgan, Apache Corp, Whiting Petroleum, Oceaneering International and Petrobras

  • Abercrombie (ANF) Upgraded to Buy: Here's Why
    zacks.com

    Abercrombie (ANF) Upgraded to Buy: Here's Why

    Abercrombie (ANF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Air Lease (AL) Upgraded to Buy: What Does It Mean for the Stock?
    zacks.com

    Air Lease (AL) Upgraded to Buy: What Does It Mean for the Stock?

    Air Lease (AL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Adecoagro (AGRO) Upgraded to Buy: What Does It Mean for the Stock?
    zacks.com

    Adecoagro (AGRO) Upgraded to Buy: What Does It Mean for the Stock?

    Adecoagro (AGRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • The Zacks Analyst Blog Highlights: Exxon Mobil, ONEOK, FedEx, Facebook and PulteGroup
    zacks.com

    The Zacks Analyst Blog Highlights: Exxon Mobil, ONEOK, FedEx, Facebook and PulteGroup

    The Zacks Analyst Blog Highlights: Exxon Mobil, ONEOK, FedEx, Facebook and PulteGroup

  • The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics
    zacks.com

    The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

    The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

  • Should Value Investors Buy OchZiff Capital Management Group LLC (SCU) Stock?
    zacks.com

    Should Value Investors Buy OchZiff Capital Management Group LLC (SCU) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Is Owens Corning (OC) Stock Undervalued Right Now?
    zacks.com

    Is Owens Corning (OC) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Are Investors Undervaluing Michaels (MIK) Right Now?
    zacks.com

    Are Investors Undervaluing Michaels (MIK) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Are Investors Undervaluing Cowen Group (COWN) Right Now?
    zacks.com

    Are Investors Undervaluing Cowen Group (COWN) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Warren Buffett's 5 Most Spectacular Earnings Charts
    zacks.com

    Warren Buffett's 5 Most Spectacular Earnings Charts

    Did you know that Berkshire Hathaway has positions in companies that have some of the best earnings surprise charts on the Street?

  • SYKE or ADP: Which Is the Better Value Stock Right Now?
    zacks.com

  • MDU vs. NJR: Which Stock Should Value Investors Buy Now?
    zacks.com

  • AL vs. WAB: Which Stock Should Value Investors Buy Now?
    zacks.com

  • TACO vs. TXRH: Which Stock Should Value Investors Buy Now?
    zacks.com

    TACO vs. TXRH: Which Stock Should Value Investors Buy Now?

    TACO vs. TXRH: Which Stock Is the Better Value Option?

  • TGT or TJX: Which Is the Better Value Stock Right Now?
    zacks.com

  • QDEL vs. RMD: Which Stock Is the Better Value Option?
    zacks.com

  • AB or SEIC: Which Is the Better Value Stock Right Now?
    zacks.com

  • CE vs. ECL: Which Stock Is the Better Value Option?
    zacks.com

  • Top Ranked Momentum Stocks to Buy for January 14th
    zacks.com

    Top Ranked Momentum Stocks to Buy for January 14th

    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 14th

  • Is VALE (VALE) Outperforming Other Basic Materials Stocks This Year?
    zacks.com

    Is VALE (VALE) Outperforming Other Basic Materials Stocks This Year?

    Is (VALE) Outperforming Other Basic Materials Stocks This Year?

  • High Cat Loss to Hurt RenaissanceRe's (RNR) Underwriting Results
    zacks.com

    High Cat Loss to Hurt RenaissanceRe's (RNR) Underwriting Results

    RenaissanceRe (RNR) expects net negative impact of around $170 million on fourth-quarter 2020 results due to persistent occurrence of catastrophe events.

  • Power-packed ETFs for Your Portfolio in 2021
    zacks.com

    Power-packed ETFs for Your Portfolio in 2021

    We have highlighted a pack of ETFs that are poised to outperform in 2021.

  • Plug Power (PLUG) Looks Good: Stock Adds 5.3% in Session
    zacks.com

    Plug Power (PLUG) Looks Good: Stock Adds 5.3% in Session

    Plug Power (PLUG) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

  • Morningstar ships market monitoring platform
    finextra.com

    Morningstar ships market monitoring platform

    Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today announced the Morningstar Market Monitoring platform, a real-time information and market insights web-based application, designed to empower advisors, traders, and market analysts with the customized set of information they need to make sound financial decisions for investors.

  • Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag
    zacks.com

    Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag

    Harpoon (HARP) gets Orphan Drug designation by the FDA for HPN217 for the treatment of multiple myeloma.

  • Initial Jobless Claims Spikes
    zacks.com

  • Marinus (MRNS) Gets Positive FDA Response for Ganaxolone Study
    zacks.com

    Marinus (MRNS) Gets Positive FDA Response for Ganaxolone Study

    Marinus (MRNS) gets positive FDA response for phase III Marigold study on oral ganaxolone in children and young adults with CDKL5 deficiency disorder that appears sufficient to support the NDA filing.

  • Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down
    zacks.com

    Esperion (ESPR) Reports Q4 Preliminary Results, Stock Down

    Esperion (ESPR) reports fourth-quarter preliminary results and provides guidance for operating expense in 2021. The company in-licenses oral PCSK9 inhibitor program.

  • Alexion (ALXN) to Pause Enrollment in COVID-19 Study on Ultomiris
    zacks.com

    Alexion (ALXN) to Pause Enrollment in COVID-19 Study on Ultomiris

    Alexion (ALXN) decides to stop further enrollment in the late-stage study of Ultomiris in adults with severe COVID-19 requiring mechanical ventilation due to lack of efficacy.

  • 5 Best-in-Bracket New Year Resolution Stocks to Snap Up Now
    zacks.com

    5 Best-in-Bracket New Year Resolution Stocks to Snap Up Now

    Here we discuss five top-ranked stocks – SFM, MNST, HIBB, SNBR, and WGO – that are lucrative bets as Americans adapt to an active lifestyle and look to commit to their new year resolutions in 2021.

  • ViacomCBS (VIAC) and Sinclair Ink Multi-Year Affiliation Deal
    zacks.com

    ViacomCBS (VIAC) and Sinclair Ink Multi-Year Affiliation Deal

    ViacomCBS (VIAC) and Sinclair enter into a multi-year affiliation agreement to provide CBS network affiliation for Sinclair stations in 13 markets.

  • Q4 Earnings Season Gets Underway
    zacks.com

    Q4 Earnings Season Gets Underway

    S&P 500 earnings are expected to be down 9.8% on 0.3% higher revenues, which would follow a 7.0% earnings decline in Q3 on 0.7% lower revenues.

  • Sarepta (SRPT) Inks New Gene Editing Research Collaboration
    zacks.com

    Sarepta (SRPT) Inks New Gene Editing Research Collaboration

    Sarepta (SRPT) signs agreement with Genevant to develop lipid nanoparticle-based gene editing medicines targeting neuromuscular indications.

  • Company News for Jan 14, 2021
    zacks.com

  • Freshpet's (FRPT) Preliminary Q4 Sales Numbers Indicate Y/Y Growth
    zacks.com

    Freshpet's (FRPT) Preliminary Q4 Sales Numbers Indicate Y/Y Growth

    Freshpet's (FRPT) preliminary net sales for the fourth quarter suggest 29% year-over-year growth. Solid demand has been aiding the company, though supply-related limitations have been concerning.

  • Is Jack in the Box (JACK) Poised to Ride on Growth Trajectory?
    zacks.com

    Is Jack in the Box (JACK) Poised to Ride on Growth Trajectory?

    Jack in the Box (JACK) is gaining from solid performance of Tiny Taco, menu innovation and digitalization.

  • Stock Market News for Jan 14, 2021
    zacks.com

    Stock Market News for Jan 14, 2021

    Benchmarks closed mixed on Wednesday as the House prepared to vote to impeach President Trump for the second time.

  • Jobless Claims Spike to 965K, Highest Since Late Spring
    zacks.com

    Jobless Claims Spike to 965K, Highest Since Late Spring

    965K new jobless claims were filed last week, much higher than the 800K expected, and even higher than the downwardly revised 784K reported a week ago.

  • Stocks to Gain From Small Business Shift to Digitization
    zacks.com

    Stocks to Gain From Small Business Shift to Digitization

    Companies in the payments ecosystem serving small businesses are poised to gain from their increasing inclination toward business digitization.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Entdecke die 6 ETFs in denen Morningstar, Inc am höchsten gewichtet ist Insgesamt in 7 ETFs enthalten

Dir gefallen die Informationen zu Morningstar Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Morningstar Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Morningstar Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Morningstar Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic